VTRS News and Press, Viatris Inc. From 03/14/24

2024-03-14 09:53:00 ET Viatris (NASDAQ: VTRS) is a large and diverse pharmaceutical business that spun off from Pfizer in 2020. The company's medications are in 165 countries and much of its business centers around generic drugs. But while its operations are diverse, this i...

2024-03-11 09:45:00 ET Dividend stocks are great for several reasons. Some use the regular payouts they offer to complement their income, whether in retirement or otherwise, while others reinvest the money to boost long-term returns. Dividend stocks have generally outperformed their non-div...

2024-03-11 09:43:30 ET More on Viatris Up 25%, I Still Believe 4%-Yielding Viatris Is Up To 60% Undervalued Viatris Inc. (VTRS) Q4 2023 Earnings Call Transcript Viatris Reduces Debt But Faces Growth Hurdles Dividend rally: Top 10 large-cap performers in 2024 ...

2024-03-08 10:21:57 ET More on Teva Pharmaceutical Teva And Alvotech: Simlandi Approval Opens New Generic Market Opportunities Teva Pharmaceutical: I Need To See Top-Line Growth Return Before Starting A Position A Review Of Teva's Prospects UroGen falls as Te...

Viatris Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance PR Newswire PITTSBURGH , Feb. 28, 2024 /PRNewswire/ -- Meets 2023 Guidance for Total Revenues, Adjusted EBITDA and Free Cash Flow[1] Reports...

SilverBow Resorces Inc. (SBOW) is expected to report $2.36 for Q4 2023 FAT Brands Inc. Class B Common Stock (FATBB) is expected to report for quarter end 2023-12-31 Ecovyst Inc. (ECVT) is expected to report $0.2 for Q4 2023 MYR Group Inc. (MYRG) is expected to report $1.41 for Q4 2023...

Viatris and Idorsia Enter Into Significant Global Research and Development Collaboration PR Newswire Expands Viatris' Portfolio of Innovative Assets by Immediately Adding Two Phase 3 Assets, Selatogrel and Cenerimod, Both With Blockbuster Revenue Potential I...

2024-02-25 08:00:00 ET The last week of February promises a dynamic mix of earnings reports across various sectors. In the technology space, investors are eagerly anticipating updates from Salesforce ( NYSE: CRM ), Snowflake ( NYSE: SNOW ), Zoom Video Communications ( NASD...

2024-02-20 13:29:57 ET Viatris ( NASDAQ: VTRS ) is on track for a seven-day winning streak, gaining 11.8% over the last six trading sessions.... Read the full article on Seeking Alpha For further details see: Viatris stock set for seven straight sessions of gains

2024-02-14 18:00:17 ET Billionaire Larry Robbins' Glenview Capital Management took new positions in semiconductor firm Marvell Technology ( NASDAQ: MRVL ) and managed care player CVS Health ( CVS ) in Q4 2023, while exiting its stake in Microsoft ( NASDAQ: MSFT ) and cut...